Long term follow-up and outcome of liver transplantation from hepatitis B surface antigen positive donors

doi:10.3748/wjg.v23.i12.2095

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 23, Issue 12

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (14358)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-5) series.

Item

Count

PDF

1109

WORD

278

HTML

9020

Figures (1-2)

612

Tables (1-5)

569

Sum=11588

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1248

Download

1522

Sum=2770

Mar 28, 2017 (publication date) through Oct 19, 2025

Times Cited of This Article

Times Cited (12)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

- Full Article with Cover (PDF)
- Full Article (XML)

Editorial

World J Gastroenterol. Mar 28, 2017; 23(12): 2095-2105
Published online Mar 28, 2017. doi: 10.3748/wjg.v23.i12.2095

Table 1 Recipient characteristics at the time of liver transplantation

Case	Age	Gender	AB0	BMI	Indication	Real MELD	MELD correct	UNOS	Wating List(d)	Year LT	HCC criteria	Downstaging type (No.)
1	62	M	0	27	HCC/HBV	26	36	2A	37	2007	MILAN IN	LOC(1)¹
2	65	M	B	21	HCC/HBV	16	39	3	522	2007	MILAN IN	LOC(1) + SUR(1)
3	54	M	A	22	HCC/HBV	10	33	3	513	2007	MILAN IN	LOC(1)
4	45	M	A	24	HCC/HBV	14	34	2B	419	2007	MILAN OUT	LOC (3)
5	62	M	0	29	HCC/HBV	12	33	3	445	2008	MILAN OUT	LOC (2)
6	53	M	0	28	HCC/HBV	12	35	2B	515	2008	MILAN IN	LOC (1)
7	45	M	A	23	HCV/HBV	24	24	2A	101	2005
8	64	M	B	27	HBV/HCV	33	33	2A	478	2005
9	26	M	A	23	HBV	23	23	2B	742	2005
10	64	M	A	22	HCC/HBV	11	23	2B	144	2005	MILAN IN	LOC (2)
11	65	F	B	25	HCC/HBV	12	24	2A	195	2006	MILAN IN	LOC (2)
12	56	M	A	24	HCC/HBV	10	24	2B	217	2006	MILAN OUT	LOC (5)
13	61	F	0	23	HCC/HBV	14	30	2B	352	2006	MILAN IN	LOC (2)
14	59	M	A	24	HBV	30	30	2B	118	2007
15	48	F	A	27	CBS	21	33	2A	82	2007
16	65	M	A	24	HCC/HBV	8	25	2B	358	2009	MILAN IN	LOC (2)
17	57	M	A	30	HCC/HBV	14	39	2B	576	2009	MILAN OUT	LOC (7)
18	55	M	B	28	HCC/HBV	18	26	2B	38	2009	MILAN IN	LOC (3)
19	65	M	A	24	HCC/HBV	7	25	2B	371	2009	MILAN IN	LOC (3)
20	63	M	A	28	HCC/HBV	16	25	2B	1962	2010	MILAN IN	LOC (2)
21	60	M	A	34	HCC/HBV	10	27	2B	330	2010	MILAN OUT	LOC (1) + SUR (1)
22	61	M	A	24	HBV	11	11	3	855	2010
23	67	M	0	19	HBV	16	16	2B	742	2004
24	55	M	A	24	HBV	17	17	3	127	2004
25	60	F	0	29	HBV/HCV	17	17	2B	961	2004
26	55	M	A	26	HCC/HBV	10	20	3	748	2005	MILAN IN	LOC (1)
27	54	M	A	27	HCC/HBV	13	19	3	134	2006	MILAN OUT	LOC (2)
28	67	M	0	22	HCC/HBV	12	29	3	575	2009	MILAN IN	LOC (1) + SUR (1)

¹LOC: Locoregional therapy [transcatheter arterial chemoembolization (TACE) and/or radiofrequency ablation (RITA)]. SUR: Surgery; MELD: Model for end-stage disease; BMI: Body mass index; LT: Liver transplantation; HCC: Hepatocellular carcinoma; CBS: Secondary biliary cirrhosis; HCV: Hepatitis C virus.

Full Size Table

Table 2 Recipient characteristics n (%)

Recipient variables	n = 28
Transplant center (No. of patients)
Modena	6 (21.4)
Bologna	16 (57.1)
Padova	6 (21.4)
Gender
Male	24 (85.7)
Female	4 (14.3)
AB0 blood group
Isogroup	28 (100)
0	7 (25)
A	17 (60.7)
B	4 (14.3)
Age (yr), mean (range, SD)	57.6 (26-67, ± 8.7)
Body mass index, mean (range, SD)	25.3 (19-34, ± 3.1)
Real MELD score, mean (range, SD)	15.6 (7-33, ± 6.5)
Correct MELD score, mean (range, SD)	26.7 (11-39, ± 7.2)
UNOS status
2A	5 (17.5)
2B	15 (53.6)
3	8 (28.6)
Time waiting list (d), mean (range, SD)	452 (37-1962, ± 393.5)
Associated hepatocellular carcinoma	19 (69.7)
Meeting Milan criteria	13 (46.4)
Meeting UCSF criteria	6 (21.4)
HBsAg status
Positive	23 (82.1)
Negative	5 (17.9)
HBV DNA positive at LT	12 (52.1)
HCV co-infection	4 (14.3)
HDV co-infection	0

UCSF: University of California, San Francisco; LT: Liver transplantation; HCV: Hepatitis C virus; HDV: Hepatitis D virus; MELD: Model for end-stage disease.

Full Size Table

Table 3 Donor characteristics

Case	Age	Gender	AB0 Gr.	BMI (kg/m²)	Cause of death	Time ICU (d)	Sodium (mEq/mL)	Vasopressors	Histologic activity index		Graft steatosis macro
Case	Age	Gender	AB0 Gr.	BMI (kg/m²)	Cause of death	Time ICU (d)	Sodium (mEq/mL)	Vasopressors	Grading	Staging	Graft steatosis macro
1	59	M	0	26	CH	2	165	No	1	0	20%
2	13	F	B	19	T	21	161	Yes	2	0	0%
3	69	M	A	24	CH	3	152	No	0	0	0%
4	72	F	A	27	CH	7	150	No	1	0	35%
5	66	M	0	22	CH	5	137	Yes	3	1	0%
6	60	M	0	26	CH	4	158	No	2	0	0%
7	73	M	A	26	CH	2	151	Yes	2	1	0%
8	51	M	B	23	CH	6	149	Yes	3	1	10%
9	54	M	A	24	T	13	160	Yes	2	1	10%
10	72	F	A	23	T	2	148	No	2	0	0%
11	60	F	B	29	CH	8	162	Yes	3	1	5%
12	65	M	A	29	CH	3	140	Yes	4	1	30%
13	50	M	0	24	CH	12	141	Yes	2	1	3%
14	48	M	A	23	T	2	143	No	4	1	5%
15	26	M	A	23	T	1	145	Yes	1	0	0%
16	52	F	A	28	CH	1	155	Yes	4	1	0%
17	79	F	A	24	CH	19	136	No	0	0	0%
18	46	F	B	29	CH	2	158	No	0	0	0%
19	61	M	A	29	CH	3	156	No	1	1	10%
20	53	F	A	25	CH	6	154	Yes	2	1	4%
21	44	F	A	24	CH	6	144	Yes	4	1	5%
22	23	F	A	21	other	7	149	Yes	1	1	0%
23	57	F	0	24	CH	4	147	Yes	0	0	0%
24	59	M	A	24	CH	1	160	Yes	0	0	5%
25	35	F	0	23	CH	1	140	Yes	1	0	0%
26	36	M	A	25	T	2	146	Yes	3	1	0%
27	23	M	A	29	T	2	147	Yes	0	0	0%
28	66	F	0	27	CH	3	151	Yes	1	0	10%

BMI: Body mass index; CH: Cerebral hemorrhage; T: Trauma; ICU: Intensive care unit.

Full Size Table

Table 4 Serological state of the recipient/donor

Case	HBsAg	HBsAb	HBcAb	HBeAg	HBeAb	HBV DNA	HDV	HDV RNA	HCV Ab	Therapy pre-LT	Mutation
R1	+	-	+	-	+	-	-	-	-	Lam	No
D1	+	-	+	-	+	+	-	-	-	No	-
R2	+	-	+	-	+	-	-	-	-	Lam	No
D2	+	-	+	-	+	+	-	-	-	No	-
R3	+	-	+	-	+	+	-	-	-	Lam + Adef	Yes
D3	+	-	+	-	+	+	-	-	-	No	-
R4	+	-	+	+	-	-	-	-	-	Lam	No
D4	+	-	+	-	+	-	-	-	-	No	-
R5	+	-	+	-	+	+	-	-	-	Lam + Adef	Yes
D5	+	-	+	-	+	-	-	-	-	No	-
R6	+	-	+	-	+	-	+	-	-	Lam	No
D6	+	-	+	-	+	+	-	-	-	No	-
R7	-	+	+	-	-	-	-	-	+	No	No
D7	+	-	+	+	-	+	-	-	+	No	-
R8	-	+	+	-	-	-	-	-	+	No	No
D8	+	-	+	-	+	+	-	-	-	No	-
R9	+	-	+	+	-	+	-	-	-	Lam	No
D9	+	-	+	+	-	+	-	-	-	No	-
R10	+	-	+	-	+	-	-	-	-	Lam	No
D10	+	-	+	+	-	+	-	-	-	No	-
R11	-	+	+	-	-	-	-	-	+	No	No
D11	+	-	+	+	-	+	-	-	+	No	-
R12	+	+	+	-	+	+	-	-	-	Lam	No
D12	+	-	+	-	+	+	-	-	-	No	-
R13	+	-	+	-	+	-	-	-	-	Lam	No
D13	+	-	+	+	-	+	-	-	-	No	-
R14	+	-	+	-	+	+	-	-	-	Lam	No
D14	+	-	+	-	+	-	-	-	-	No	-
R15	-	-	+	-	+	-	-	-	-	No	No
D15	+	-	+	-	+	+	-	-	-	No	-
R16	+	-	+	-	+	+	-	-	-	Lam	No
D16	+	-	+	-	+	+	-	-	-	No	-
R17	+	-	+	-	+	+	-	-	-	Lam + Adef	Yes
D17	+	-	+	+	-	+	-	-	-	No	-
R18	+	-	+	-	+	+	-	-	-	Lam	No
D18	+	-	+	-	+	-	-	-	-	No	-
R19	+	-	+	+	-	+	-	-	-	Adefovir	No
D19	+	-	+	+	-	+	-	-	-	No	-
R20	+	-	+	-	+	+	-	-	-	Lam + Adef	No
D20	+	-	+	+	-	+	-	-	-	No	-
R21	+	-	+	-	+	-	-	-	-	NA	No
D21	+	-	+	+	-	+	-	-	-	No	-
R22	+	-	+	-	+	-	-	-	-	Lam	No
D22	+	-	+	+	-	+	-	-	-	No	-
R23	+	-	+	-	+	-	-	-	-	Lam	No
D23	+	-	+	-	+	-	-	-	-	No	-
R24	+	-	+	-	+	+	-	-	-	Lam	Yes
D24	+	-	+	-	+	-	-	-	-	No	-
R25	-	+	+	-	+	-	-	-	+	No	No
D25	+	-	+	-	+	-	-	-	-	No	-
R26	+	-	+	-	+	-	-	-	-	Lam	No
D26	+	-	+	+	-	+	-	-	-	No	-
R27	+	-	+	-	+	-	-	-	-	Adef	Yes
D27	+	-	+	-	+	+	-	-	-	No	-
R28	+	-	+	-	+	-	+	-	-	Lam	No
D28	+	-	+	+	-	+	-	-	-	No	-

R: Recipient; D: Donor; LT: Liver transplant; Lam: Lamivudine; Adef: Adefovir.

Full Size Table

Table 5 Literature review

Ref.	Year	Cases
Franchello et al[46]	2005	3
Jiang et al[34]	2011	6
Loggi et al[37]	2012	10
Saidi et al[48]	2013	92
Choi et al[49]	2013	8
Li et al[39]	2013	78
Ju et al[50]	2013	23
Yu et al[51]	2014	42
Krishnamoorthi et al[47]	2014	28
Jeng et al[52]	2015	14

Full Size Table

Citation: Ballarin R, Cucchetti A, Russo FP, Magistri P, Cescon M, Cillo U, Burra P, Pinna AD, Di Benedetto F. Long term follow-up and outcome of liver transplantation from hepatitis B surface antigen positive donors. World J Gastroenterol 2017; 23(12): 2095-2105
URL: https://www.wjgnet.com/1007-9327/full/v23/i12/2095.htm
DOI: https://dx.doi.org/10.3748/wjg.v23.i12.2095